骨肉瘤患者预后研究的发展

Advancement in Prognostic Studies among Patients Diagnosed with Osteosarcoma

骨肉瘤是一种源自间充质细胞的恶性骨肿瘤,其特征是肿瘤细胞直接形成骨或骨样组织的增殖,通常情况下,骨肉瘤起源于骨骼,极少数情况下起源于软组织。癌症患者的预后是指患者在一定时间范围内发展为结局事件。预后研究旨在探究患者在特定基线健康状态(起点)下与未来结果(终点)之间的关联,以促进健康状况的改善。因此,预后研究结果应该是临床决策、医疗保健政策、发现和评估患者管理的新方法中不可或缺的一部分,作者根据相关的参考文献和数据总结分析了恶性骨肿瘤预后研究的发展。

Osteosarcoma is a malignancy arising from mesenchymal cells, characterized by the direct formation of bone or bone-like tissue by tumor cells. While primarily originating from bone, there are rare instances in which osteosarcoma originates from soft tissues. The prognosis of cancer patients is defined as the occurrence of outcome events within a specific timeframe. Prognostic studies seek to investigate the relationship between patients’ initial health status and subsequent outcomes, with the goal of improving healthcare conditions. Consequently, the findings from prognostic studies should be considered vital in clinical decision-making, healthcare policies, and the identification and assessment of novel approaches in patient management. Drawing upon pertinent literature and data, the author provides a comprehensive overview of the advancements made in prognostic studies concerning malignant bone tumors.